Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2001.03571.xPMID 11232722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

  2000cited by this paper
• The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

  1999cited by this paper
• Prevalence of hepatitis C virus infection in the United States.

  1999cited by this paper
• Risk Factors for Infective Endocarditis

  1999cited by this paper
• Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.

  1998cited by this paper
• [The prevalence of hepatitis C virus infection].

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis.

  1998cited by this paper
• Diabetes Mellitus and Interferon Therapy

  1997cited by this paper
• Diabetes mellitus and interferon-alpha therapy.

  1995cited by this paper
• Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.

  1995cited by this paper
• Effect of Interferon on Glucose Tolerance and Insulin Sensitivity

  1989cited by this paper

• Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet–Pharmacotherapy Interactions

  2024cites this paper
• Characteristics of Interferon-Associated Diabetes Mellitus in Past 30 Years: A Review.

  2022cites this paper
• Chapter 10 Diabetic Ketoacidosis

  2019cites this paper
• Interferon therapy in hepatitis C leading to chronic type 1 diabetes.

  2015cites this paper
• Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

  2014cites this paper
• Hepatitis C virus and type 1 diabetes.

  2013cites this paper
• Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review

  2011cites this paper
• Drug-Induced Endocrine Autoimmunity

  2011cites this paper
• Chapter 16. Drug-Induced Diabetes

  2010cites this paper
• Association of pancreatic autoantibodies and human leukocyte antigen haplotypes with resolution of diabetes mellitus after therapy for hepatitis C virus infection in patients with HIV infection: case report and review of literature.

  2009cites this paper
• Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.

  2007cites this paper
• Resolution of diabetes in type 2 diabetic patient treated with IFN-&agr; and ribavirin for hepatitis C

  2006cites this paper
• Diabetic ketoacidosis.

  2005cites this paper
• Late Development of Diabetes mellitus after Interferon-Alfa and Ribavirin Therapy for Chronic Hepatitis C: A Case Report

  2005cites this paper
• Differing manifestations of hepatitis C and tacrolimus on hospitalized diabetes mellitus occurring after kidney transplantation.

  2005cites this paper
• Rare complication of interferon alpha therapy: retinal vein thrombosis.

  2005cites this paper
• [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].

  2004cites this paper
• Autoantikörper gegen Inselzellantigene und Diabetes mellitus Typ 1 unter Interferon alpha-Kombinationstherapie

  2004cites this paper
• Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

  2003cites this paper
• CASE REPORT: Diabetes Mellitus During Interferon Therapy for Chronic Viral Hepatitis

  2002cites this paper
• Diabetes mellitus during interferon therapy for chronic viral hepatitis.

  2002cites this paper